Laminta (Xiamen) Bio Technology Ltd. – Trademark Portfolio

Entity Type: 99

Laminta (Xiamen) Bio Technology Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include LAMINTA. The owner is based in Xiamen, Fujian.

Huli District,

Room 902-3, No. 54 Huli Avenue,

Xiamen, Fujian 361000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LAMINTA
LAMINTA
Registered 2024
LAMINTA
LAMINTA
Registered 2024

Trademark Classifications

Laminta (Xiamen) Bio Technology Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Laminta (Xiamen) Bio Technology Ltd. have?

Laminta (Xiamen) Bio Technology Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Laminta (Xiamen) Bio Technology Ltd. file in?

Laminta (Xiamen) Bio Technology Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Laminta (Xiamen) Bio Technology Ltd.'s most well-known trademarks?

Laminta (Xiamen) Bio Technology Ltd.'s registered trademark portfolio includes well-known marks such as LAMINTA. These are among 2 currently registered trademarks in the portfolio.

What is Laminta (Xiamen) Bio Technology Ltd.'s trademark registration success rate?

Laminta (Xiamen) Bio Technology Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.